NATCO Pharma Limited (NSE:NATCOPHARM)
India · Delayed Price · Currency is INR 864.80
+2.80 (0.32%)
Sep 1, 2025, 3:30 PM IST
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 154.89 billion as of August 29, 2025. Its market cap has decreased by -41.37% in one year.
Market Cap
154.89B
Enterprise Value
132.77B
Revenue
43.96B
Ranking
n/a
PE Ratio
9.12
Stock Price
864.80
Market Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 154.89B, an increase of 35,973.21%. That is a compound annual growth rate of 24.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2025 | 154.89B | -37.66% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | 175.25B | 62.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,825.74B |
| Divi's Laboratories | 1,627.72B |
| Cipla | 1,283.84B |
| Apollo Hospitals Enterprise | 1,094.20B |
| Mankind Pharma | 1,020.09B |
| Zydus Lifesciences | 987.17B |
| Fortis Healthcare | 688.14B |
| Alkem Laboratories | 634.11B |